Having HIV May Mean Getting Heart Health Medications OverlookedA new study at Duke University has uncovered that the school doled out hypertension drugs, statins and aspirin to HIV-positive people at a much lower rate than their HIV-negative patients.
That’s despite the fact that the two groups had heart health risks that were essentially the same. Could this be happening elsewhere in the U.S.?

Having HIV May Mean Getting Heart Health Medications Overlooked

A new study at Duke University has uncovered that the school doled out hypertension drugs, statins and aspirin to HIV-positive people at a much lower rate than their HIV-negative patients.

That’s despite the fact that the two groups had heart health risks that were essentially the same. Could this be happening elsewhere in the U.S.?

The AIDS Grove Just Renamed Its Youth Scholarship to Honor Pedro Zamora!

Zamora was an AIDS educator, activist and reality television star. At the age of 22, the HIV-positive gay Latino shared his journey with the virus on MTV’s The Real World 3: San Francisco. The show aired in 1994. The scholarship will honor his contributions 20 years after his passing.

High school seniors and college freshman, sophomores and juniors ages 27 and younger are eligible. They must demonstrate current public service and leadership roles in the HIV/AIDS fight. They also must intend to pursue a career that will have with a clear impact on the epidemic.

Applications are being accepted through Wednesday, October 15. Recipients will be announced Monday, December 1, which is World AIDS Day. Awards range from $2,500 to $5,000.

POZ Stories: Rob Toth, Lakewood OHPositive since 1988

"I got my HIV test results under the name G.H.W. Bush at a local free clinic. I remember the lady telling me I was HIV positive; I remember hating her little pearl earrings, the navy blazer she was wearing and the small, unkempt room. Her post-counseling talk was rather like the teacher in Peanuts cartoon: “wah-wah-wah-wah-wah.” I sat numb in the office. Then I silently walked the long, rainy path by the river to my home…."

Click here for the rest of Toth’s submission, or here to submit your own POZ story on our site. Together, we can help fight stigma and shame, increase awareness, and educate the community about living with HIV.

POZ Stories: Rob Toth, Lakewood OH
Positive since 1988

"I got my HIV test results under the name G.H.W. Bush at a local free clinic. I remember the lady telling me I was HIV positive; I remember hating her little pearl earrings, the navy blazer she was wearing and the small, unkempt room. Her post-counseling talk was rather like the teacher in Peanuts cartoon: “wah-wah-wah-wah-wah.” I sat numb in the office. Then I silently walked the long, rainy path by the river to my home…."

Click here for the rest of Toth’s submission, or here to submit your own POZ story on our site. Together, we can help fight stigma and shame, increase awareness, and educate the community about living with HIV.

Did you know that folks ages 40-49 make up the highest percentage of people diagnosed with advanced AIDS in the U.S.?

Here are their stories.

“I’d stayed HIV negative so long I thought I was Superman and started having condom-free sex.”

“We used petroleum jelly instead of water-based lubricant.”

“I caved to affection. And once you allow them not to wear a condom the first time, that’s it.”

“All I can say is, I wanted to experience the joy of the moment. I’m a heavy guy, and the thought that anyone wanted to have sex with me was encouraging.”

“We may feel more isolated, we’re not going out to clubs anymore, we may feel that people are judging us because we’re older and ‘should have known better.’”

ViiV’s New HIV Drug “Trii” Has Officially Been FDA-Approved
Triumeq is a tablet that must be taken daily. Each tablet contains 50 mg dolutegravir, 600 mg abacavir, and 300 mg lamivudine. The correct dose is one pill taken once daily, either with or without food.
FDA approval is based on data from two clinical trials: In one trial involving people starting ARV therapy for the first time, the regimen was found to be superior to Atripla. Another study confirmed that taking Triumeq results in blood levels of the ARVs equivalent to all 3 drugs taken together as separate tablets.
It is not recommended for people with known HIV resistance to abacavir, lamivudine, or any of the approved intergrase inhibitors.
Click here for a complete guide to the latest fixed-dose, once-daily combination tablet, Triumeq.

ViiV’s New HIV Drug “Trii” Has Officially Been FDA-Approved

  • Triumeq is a tablet that must be taken daily. Each tablet contains 50 mg dolutegravir, 600 mg abacavir, and 300 mg lamivudine. The correct dose is one pill taken once daily, either with or without food.
  • FDA approval is based on data from two clinical trials: In one trial involving people starting ARV therapy for the first time, the regimen was found to be superior to Atripla. Another study confirmed that taking Triumeq results in blood levels of the ARVs equivalent to all 3 drugs taken together as separate tablets.
  • It is not recommended for people with known HIV resistance to abacavir, lamivudine, or any of the approved intergrase inhibitors.


Click here for a complete guide to the latest fixed-dose, once-daily combination tablet, Triumeq.